Registered Botswana · BoMRA

LAXETTE

senna

BOT0801175 SOLUTION

What it does

Senna is a natural laxative used to relieve constipation.

Commonly used for: constipation, occasional constipation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
BOT0801175
Registration date
2008-03-28
Expiry date
-
Status
Registered/Compliant
Active ingredient
senna
Dosage form
SOLUTION
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Cipla Ltd
Country of origin
South Africa
Manufacturer location
Lal Bahadur Shastri Marg, Chandan Nagar, Vikhroli West, Mumbai, Maharashtra 400083, India

Source: Botswana Medicines Regulatory Authority · fetched 2026-04-15 20:41:32 · updated 2026-05-12 08:02:15

Disclaimer: This information is sourced from Botswana Medicines Regulatory Authority (Botswana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Senna is a natural laxative used to relieve constipation.

What it treats

  • constipation
  • occasional constipation

How it works

Senna works by stimulating the muscles in the bowel, helping to move stool through the intestines.

Who it's for

Senna is suitable for adults and children who need relief from constipation.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Senna

BNF-referenced

Senna is a natural stimulant laxative derived from the leaves and pods of the Senna plant, primarily used to treat constipation. It works by stimulating bowel movements through irritation of the intestinal lining, which increases peristalsis and enhances the motility of the large intestine. It is commonly employed in both general and palliative care settings.

Indications

  • Constipation
  • Palliative care for bowel cleansing

Dosage

Children: Child 1 month–3 years: 3.75–15 mg once daily, adjusted according to response. Child 4–17 years: 3.75–30 mg once daily, adjusted according to response.

Adults: 7.5–15 mg once daily (max. per dose 30 mg daily), typically taken at bedtime. The initial dose should be low and increased gradually as needed, with higher doses prescribed under medical supervision.

Mechanism of action

Senna contains sennosides, which are metabolized in the colon to form active compounds that stimulate the peristaltic movement of the intestines. This promotes bowel evacuation by increasing the contraction of intestinal muscles and enhancing fluid secretion into the bowel, leading to softer stools.

Pharmacodynamics

The pharmacodynamic effect of senna includes increased intestinal motility and secretion of electrolytes and water into the intestines, resulting in softened stools and facilitation of bowel movements. Side effects may include abdominal cramps and gastrointestinal disturbances, as well as potential skin reactions.

Pharmacokinetics

Senna is not absorbed significantly in the gastrointestinal tract; its active metabolites exert their effects locally in the intestines. The onset of action is typically within 6 to 12 hours when taken orally. Metabolism occurs in the gut, and excretion is primarily via feces, with minimal systemic absorption.

Contra-indications

  • Acute abdominal conditions
  • Acute inflammatory bowel disease
  • Intestinal obstruction
  • Severe dehydration

Adverse effects

  • Abdominal cramps
  • Asthenia
  • Gastrointestinal disorders
  • Skin reactions
  • Urine discolouration

Precautions

  • Excessive use of stimulant laxatives can cause diarrhea and related effects such as hypokalaemia
  • Local irritation - avoid prolonged contact with skin (incontinent patients or infants wearing nappies, risk of irritation and excoriation)
  • Rodent studies indicate potential carcinogenic risk

Pregnancy

Manufacturers advise to avoid - limited information available.

Breast-feeding

Manufacturers advise to avoid - no information available.

Storage

Store at room temperature, away from moisture and heat.

Formulations

  • Oral suspension
  • Tablets
  • Syrup
  • Suppositories
BNF 85 (British National Formulary) p.84 BNF for Children 2019-2020 p.70 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Senna

PubChem CID 73111

Molecular formula: C42H38O20

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.